Jens has more than 18 years of biopharma venture capital and company creation experience and 10 years of operational experience in drug discovery and development. Before joining Apollo Health Ventures as Managing Partner, Jens served as President of GlaxoSmithKline’s corporate venture fund SR One for eight years. Jens is also co-founder and was Managing Director of GSK’s Action Potential Venture Capital (APVC) fund which invests in pioneering bioelectronic technologies. Previously, Jens was a General Partner at TVM Capital leading early-stage investments in Boston.
Jens is a Kauffman Fellow, a member of the EU-sponsored Gold Track Expert Council, and a passionate mentor for entrepreneurs and start-up teams in the area of innovative life science and healthcare IT. Before his investment career, Jens was leading research teams and pharma collaborations at Enanta Pharmaceuticals (NASDAQ: ENTA) and Mitotix, Inc.